SCHEMBL9999183

SCHEMBL9999183

CCc1cc(Cl)c(C(=O)C(C)C)cc1C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 1/20 0.34
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
BAZ2B Q9UIF8 1/20 0.33
BAZ2A Q9UIF9 1/20 0.33
CA12 O43570 1/20 0.33
CA9 Q16790 1/20 0.33
SCN9A Q15858 1/20 0.33
CHRNA1 P02708 1/20 0.33
CHRNG P07510 1/20 0.33
CHRNB1 P11230 1/20 0.33
CHRNB2 P17787 1/20 0.33
SLC6A2 P23975 1/20 0.33
CHRNB4 P30926 1/20 0.33
SLC6A4 P31645 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA4 P43681 1/20 0.33
SLC6A3 Q01959 1/20 0.33
CHRND Q07001 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9999441 0.81 LMNA (0.34) KMT2A
SCHEMBL17732591 0.80 FFAR1 (0.41) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL9999181 0.76 HTT (0.41) NPSR1GAA
SCHEMBL19932056 0.74 NOS3 (0.40) TSHRNPSR1GAA
SCHEMBL15631129 0.73 ALOX15 (0.47) CA1CA2CA12CA9TSHR
SCHEMBL19931606 0.72 CD44 (0.42) CA1CA2CA12CA9TSHR
SCHEMBL13707877 0.72 POLB (0.51) TSHRMEN1KMT2APOLBGAA
SCHEMBL23652953 0.71 HPGD (0.42) TSHRNPSR1PKMALOX15ALOX12
SCHEMBL18432688 0.70 GABRP (0.43) CA1CA2CA12CA9TSHR
SCHEMBL5453166 0.70 LMNA (0.40) CA1CA2CA12CA9CHRNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8314249-B2 Process for the preparation of [4-(2-chloro-4-methoxy-5-methylphenyl)-5-methyl-thiazolo-2-yl]-[2-cyclopropyl-1-(3-fluoro-4-methylphenyl SANOFI (FR) 2012-11-20 US disclosed
US-20120083608-A1 PROCESS FOR THE PREPARATION OF [4-(2-CHLORO-4- METHOXY-5-METHYLPHENYL)-5-METHYL-THIAZOLO-2-YL]-[2-CYCLOPROPYL-1-(3-FLUORO-4-METHYLPHENYL)-ETHYL]-AMINE SANOFI (FR) 2012-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120083608-A1 PROCESS FOR THE PREPARATION OF [4-(2-CHLORO-4- METHOXY-5-METHYLPHENYL)-5-METHYL-THIAZOLO-2-YL]-[2-CYCLOPROPYL-1-(3-FLUORO-4-METHYLPHENYL)-ETHYL]-AMINE CYP4B1, CYP3A4, CYP4F2 PTGES 1824/4885CA1 3658/4885CA2 4232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.